Technical Analysis for ZCOR - Egalet Corp

Grade Last Price % Change Price Change
grade C 1.6 6.67% 0.1000
ZCOR closed up 6.67 percent on Tuesday, April 7, 2020, on 2 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical ZCOR trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
New Downtrend Bearish 6.67%
Narrow Range Bar Range Contraction 6.67%
Wide Bands Range Expansion 6.67%
Hammer Candlestick Bullish 14.29%
Wide Range Bar Range Expansion 14.29%
Wide Bands Range Expansion 14.29%
Older signals for ZCOR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
RTT Euphoriants Pharmaceutical Psychoactive Drugs Chemical Compounds Morphinans Opioids Heroin Morphine Oxycodone Acute And Chronic Pain Analgesic Hydrocodone Pain Products Short Term Management Alternative Treatments Immediate Release Oxycodone Product Morphine Product Nasal Spray Sprix Nasal Spray

Is ZCOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.0
52 Week Low 1.0
Average Volume 4,699
200-Day Moving Average 0.0000
50-Day Moving Average 2.0946
20-Day Moving Average 1.7198
10-Day Moving Average 1.5616
Average True Range 0.1176
ADX 26.94
+DI 24.0962
-DI 53.5999
Chandelier Exit (Long, 3 ATRs ) 2.0722
Chandelier Exit (Short, 3 ATRs ) 1.4628
Upper Bollinger Band 2.3761
Lower Bollinger Band 1.0635
Percent B (%b) 0.41
BandWidth 76.3228
MACD Line -0.1789
MACD Signal Line -0.1847
MACD Histogram 0.0058
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.6000
Resistance 3 (R3) 1.6000 1.6000 1.6000
Resistance 2 (R2) 1.6000 1.6000 1.6000 1.6000
Resistance 1 (R1) 1.6000 1.6000 1.6000 1.6000 1.6000
Pivot Point 1.6000 1.6000 1.6000 1.6000 1.6000
Support 1 (S1) 1.6000 1.6000 1.6000 1.6000 1.6000
Support 2 (S2) 1.6000 1.6000 1.6000 1.6000
Support 3 (S3) 1.6000 1.6000 1.6000
Support 4 (S4) 1.6000